H Wenzl

1.7k total citations
47 papers, 1.2k citations indexed

About

H Wenzl is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, H Wenzl has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 18 papers in Genetics and 15 papers in Surgery. Recurrent topics in H Wenzl's work include Microscopic Colitis (18 papers), Inflammatory Bowel Disease (17 papers) and Clostridium difficile and Clostridium perfringens research (7 papers). H Wenzl is often cited by papers focused on Microscopic Colitis (18 papers), Inflammatory Bowel Disease (17 papers) and Clostridium difficile and Clostridium perfringens research (7 papers). H Wenzl collaborates with scholars based in Austria, Germany and United States. H Wenzl's co-authors include Wolfgang Petritsch, Christoph Högenauer, Thomas Hinterleitner, G Reicht, Guenter J. Krejs, Patrizia Kump, Berendt W. Aichbichler, John S. Fordtran, Kenneth D. Fine and Gregor Gorkiewicz and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

H Wenzl

44 papers receiving 1.2k citations

Peers

Countries citing papers authored by H Wenzl

Since Specialization

Citations

This map shows the geographic impact of H Wenzl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Wenzl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Wenzl more than expected).

Fields of papers citing papers by H Wenzl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Wenzl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Wenzl. The network helps show where H Wenzl may publish in the future.

Co-authorship network of co-authors of H Wenzl

This figure shows the co-authorship network connecting the top 25 collaborators of H Wenzl. A scholar is included among the top collaborators of H Wenzl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Wenzl. H Wenzl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment persistence of ustekinumab and vedolizumab in IBD patients is independent of prior immunogenicity to anti-TNFs: a retrospective study 2022 ·Scandinavian Journal of Gastroenterology ·Andreas Blesl, Wolfgang Petritsch, Lukas Binder, (unknown), H Wenzl, (unknown), Patrizia Kump, Christoph Högenauer	1
2	Low prevalence of gastroesophageal reflux symptoms in vegetarians 2021 ·Indian Journal of Gastroenterology ·(unknown), Regina Riedl, (unknown), Wolfgang Petritsch, H Wenzl	2
3	Successful Pregnancies After Regression of AA Amyloidosis by Anti-inflammatory Therapy in Chronic Active Crohn’s Disease 2019 ·Digestive Diseases and Sciences ·Andreas Blesl, Florian Rainer, Marion J. Pollheimer, Patrizia Kump, Franziska Durchschein, H Wenzl, Kathrin Eller, Peter Krisper, Wolfgang Petritsch, Christoph Högenauer	1
4	D-lactic acidosis – case report and review of the literature 2016 ·Zeitschrift für Gastroenterologie ·Elisabeth Fabian, Ludwig Kramer, (unknown), Christoph Högenauer, Reinhard B. Raggam, H Wenzl, Guenter J. Krejs	28
5	Clinical-Pathological Conference Series from the Medical University of Graz 2015 ·Wiener klinische Wochenschrift ·Elisabeth Fabian, (unknown), H Wenzl, Carolin Lackner, Josef Donnerer, A Ziachehabi, René Silye, R Schöfl, Guenter J. Krejs	5
6	The Toxin-Producing Pathobiont Klebsiella oxytoca Is Not Associated with Flares of Inflammatory Bowel Diseases 2015 ·Digestive Diseases and Sciences ·Ines Zollner‐Schwetz, Kathrin Herzog, Gebhard Feierl, Eva Leitner, Georg Schneditz, (unknown), Juergen Prattes, Wolfgang Petritsch, H Wenzl, Patrizia Kump, Gregor Gorkiewicz, Ellen L. Zechner, Christoph Högenauer	14
7	Withdrawal of Long-Term Maintenance Treatment with Azathioprine Tends to Increase Relapse Risk in Patients with Crohn’s Disease 2014 ·Digestive Diseases and Sciences ·H Wenzl, Christian Primas, Gottfried Novacek, Alexander Teml, (unknown), Christoph Högenauer, Harald Vogelsang, Wolfgang Petritsch, Walter Reinisch	31
8	Alteration of Intestinal Dysbiosis by Fecal Microbiota Transplantation Does not Induce Remission in Patients with Chronic Active Ulcerative Colitis 2013 ·Inflammatory Bowel Diseases ·Patrizia Kump, H Gröchenig, Stefan Lackner, Slave Trajanoski, G Reicht, K. Martin Hoffmann, Andrea Deutschmann, H Wenzl, Wolfgang Petritsch, Guenter J. Krejs, Gregor Gorkiewicz, Christoph Högenauer	194
9	A case of opportunistic skin infection with Mycobacterium marinum during adalimumab treatment in a patient with Crohn's disease 2012 ·Journal of Crohn s and Colitis ·Patrizia Kump, Christoph Högenauer, H Wenzl, Wolfgang Petritsch	16
10	A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease 2010 ·Journal of Crohn s and Colitis ·Wolfgang Miehsler, Gottfried Novacek, H Wenzl, Harald Vogelsang, P Knoflach, Arthur Kaser, Clemens Dejaco, Wolfgang Petritsch, Magdalena Kapitan, Harald Maier, W. Graninger, Herbert Tilg, Walter Reinisch	85
11	Austrian infliximab experience in Crohn's disease 2004 ·European Journal of Gastroenterology & Hepatology ·H Wenzl, Walter Reinisch, (unknown), Felix Stockenhuber, Herbert Tilg, A Kirchgatterer, Wolfgang Petritsch	17
12	Effect of oral tacrolimus (FK 506) on steroid‐refractory moderate/severe ulcerative colitis 2003 ·Alimentary Pharmacology & Therapeutics ·Christoph Högenauer, H Wenzl, Thomas Hinterleitner, Wolfgang Petritsch	87
13	Examination, Prevention and Treatment of Osteoporosis in Patients with Inflammatory Bowel Disease: Recommendations and Reality 2002 ·PubMed ·A Kirchgatterer, H Wenzl, G Aschl, (unknown), (unknown), Thomas Hinterleitner, Wolfgang Petritsch, P Knoflach	14
14	Time Course of Spontaneous Bacterial Translocation from Gastrointestinal Tract and Its Relationship to Intestinal Microflora in Conventionally Reared Infant Rats 2001 ·Digestive Diseases and Sciences ·H Wenzl, (unknown), Gebhard Feierl, Gerhardt Steinwender	29
15	Gut-Derived Bone Infection in the Neonatal Rat 2001 ·Pediatric Research ·Gerhardt Steinwender, (unknown), (unknown), H Wenzl	11
16	Effect of Fludrocortisone and Spironolactone on Sodium and Potassium Losses in Secretory Diarrhea 1997 ·Digestive Diseases and Sciences ·H Wenzl, Kenneth D. Fine, (unknown), Jack L. Porter, John S. Fordtran	7
17	Effect of Early Nutritional Deprivation and Diet on Translocation of Bacteria from the Gastrointestinal Tract in the Newborn Rat 1996 ·Pediatric Research ·Gerhardt Steinwender, (unknown), (unknown), (unknown), Manfred Ratschek, (unknown), Michael E. Höllwarth, H Wenzl	29
18	Determinants of decreased fecal consistency in patients with diarrhea 1995 ·Gastroenterology ·H Wenzl, Kenneth D. Fine, Lawrence R. Schiller, John S. Fordtran	103
19	Prevalence of Helicobacter pylori Antibodies in the Serum of Gastroenterologists in Austria 1994 ·Endoscopy ·H Pristautz, Andreas Eherer, Ruth I. Brezinschek, M. Truschnig‐Wilders, Wolfgang Petritsch, Frank Schreiber, Heinz F. Hammer, H Wenzl, Thomas Hinterleitner, G Reicht, Gernot P. Tilz, G. J. Krejs	20
20	Treatment of anemia in inflammatory bowel disease with recombinant human erythropoietin: Results in three patients 1993 ·Gastroenterology ·Jörg H. Horina, Wolfgang Petritsch, (unknown), G Reicht, H Wenzl, Heinz Sill, Guenter J. Krejs	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact